Skip to main content
Clinical Trials/NCT02783716
NCT02783716
Terminated
Not Applicable

Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure

Mayo Clinic1 site in 1 country45 target enrollmentMay 2016
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Mayo Clinic
Enrollment
45
Locations
1
Primary Endpoint
Change in vascular endothelial function
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this research study is to determine the role of blood vessel endothelial function in heart failure and the effect of Cardiac Resynchronization Therapy (CRT) on heart and endothelial function.

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
July 20, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hon-Chi Lee, M.D., Ph.D.

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • CRT Group: Patients recommended for CRT-P or CRT-D for heart failure (HF) according to current American Heart Association (AHA)/American College of Cardiology (ACC)/Heart Rhythm Society (HRS) guidelines of Left Ventricle Ejection Fraction (LVEF)\<35%, Left Bundle Branch Block (LBBB)\>120 ms, New York Heart Association (NYHA) Class II-III).
  • Control Group: Patients who undergo device (pacemaker or ICD) implantation or a pack change for sinus node dysfunction or AV blocks

Exclusion Criteria

  • Patients who are unwilling or unable to return for follow up visits 3 months after device implantation.

Outcomes

Primary Outcomes

Change in vascular endothelial function

Time Frame: baseline, 3 months

Vascular endothelial function will be measured using peripheral arterial tonometry as the reactive hyperemia index (RHI) at baseline and at 3 months.

Study Sites (1)

Loading locations...

Similar Trials